Inizio is a global strategic partner for companies in the health and life sciences sector. Formed in 2022 through the merger of UDG Healthcare and Huntsworth, and owned by private equity firm Clayton, Dubilier & Rice, Inizio combines a diverse range of capabilities to help its clients accelerate clinical development and commercialize their products. The company operates through four main divisions: Inizio Advisory (strategic consulting), Inizio Medical (medical communications and affairs), Inizio MarComms (marketing and communications, including advertising and PR), and Inizio Engage (patient and healthcare provider engagement).

Founded in

United States